The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Neutrophil Gelatinase-Associated Lipocalin: A Novel Early Urinary Biomarker for Cisplatin Nephrotoxicity
Abstract
Background: Cisplatin is one of the most widely used chemotherapeutic agents, but the risk of nephrotoxicity frequently hinders the use of higher doses to maximize its antineoplastic effects. The lack of early biomarkers has impaired our ability to initiate potential therapeutic or preventive interventions in cisplatin nephrotoxicity in a timely manner. In this study, we have explored the expression and urinary excretion of neutrophil gelatinase-associated lipocalin (NGAL) in a mouse model of cisplatin-induced nephrotoxic injury. Methods: Mice were subjected to intraperitoneal injections of 20 mg/kg (high dose) or 5 mg/kg (low dose) cisplatin. The expression of NGAL was measured in the kidney and urine by Western analysis and immunofluorescence, and compared to changes in serum creatinine and urinary N-acetyl-β-D-glucosaminidase (NAG). Results: Cisplatin resulted in tubule cell necrosis and apoptosis following the high dose, but not the low dose. By Western analysis, NGAL protein was rapidly induced in the kidney within 3 h of high-dose cisplatin. By immunofluorescence, NGAL was induced predominantly in proximal tubule cells in a punctate cytoplasmic distribution, reminiscent of a secreted protein. NGAL was easily detected in the urine by Western analysis within 3 h of cisplatin administration in a dose- and duration-dependent manner. By comparison, changes in urinary NAG or serum creatinine were not evident until 96 h after cisplatin. Using defined concentrations of purified recombinant NGAL, urinary NGAL excretion following cisplatin administration was quantified to be in the 20–80 ng/ml range. Conclusion: The results indicate that NGAL represents an early and quantitative urinary biomarker for cisplatin nephrotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749
Self-citationThadhani, R., Pascual, M., & Bonventre, J. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342207 · Cited by 1,417
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15606 · Cited by 866
Treatment of acute renal failure
Star, R. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00210.x · Cited by 816
Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury
Ichimura, T., Hung, C. C., Yang, S. A., Stevens, J. L., & Bonventre, J. V. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00285.2002 · Cited by 683
An Iron Delivery Pathway Mediated by a Lipocalin
Yang, J., Goetz, D., Li, J.-Y., Wang, W., Mori, K., Setlik, D., Du, T., Erdjument-Bromage, H., Tempst, P., Strong, R., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00710-4 · Cited by 651
Self-citationCowland, J. B., & Borregaard, N. (1997) · Genomics · doi:10.1006/geno.1997.4896 · Cited by 619
Cisplatin nephrotoxicity: molecular mechanisms.
Hanigan, M. H., & Devarajan, P. (2003) · PubMed · Cited by 476
Self-citation
Cited by
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394
Self-citationRonco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp507 · Cited by 1,104
Update on Mechanisms of Ischemic Acute Kidney Injury
Devarajan, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010017 · Cited by 1,026
Self-citationUrine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study
Bennett, M., Dent, C. L., Ma, Q., Dastrala, S., Grenier, F., Workman, R., Syed, H., Ali, S., Barasch, J., & Devarajan, P. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04010907 · Cited by 765
Self-citationZuk, A., & Bonventre, J. V. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-050214-013407 · Cited by 739
Biomarkers of Acute Kidney Injury
Vaidya, V. S., Ferguson, M. A., & Bonventre, J. V. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094615 · Cited by 729
Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review
Coca, S. G., Yalavarthy, R., Concato, J., & Parikh, C. R. (2008) · Kidney International · doi:10.1038/sj.ki.5002729 · Cited by 685
Vaidya, V. S., Ramirez, V., Ichimura, T., Bobadilla, N. A., & Bonventre, J. V. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00291.2005 · Cited by 656
Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery
Parikh, C. R., Mishra, J., Thiessen-Philbrook, H., Dursun, B., Ma, Q., Kelly, C., Dent, C., Devarajan, P., & Edelstein, C. L. (2006) · Kidney International · doi:10.1038/sj.ki.5001527 · Cited by 608
Self-citationWang, Y., Lam, K. S. L., Kraegen, E. W., Sweeney, G., Zhang, J., Tso, A. W., Chow, W.-S., Wat, N. M., Xu, J. Y., Hoo, R. L., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.075614 · Cited by 578
“Several recent reports suggest that lipocalin-2 might represent a sensitive biomarker for early renal injury (31, 32).”
BackgroundNeutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage
Bolignano, D., Donato, V., Coppolino, G., Campo, S., Buemi, A., Lacquaniti, A., & Buemi, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.020 · Cited by 581
Wagener, G., Jan, M., Kim, M., Mori, K., Barasch, J. M., Sladen, R. N., & Lee, H. T. (2006) · Anesthesiology · doi:10.1097/00000542-200609000-00011 · Cited by 565
Self-citationDent, C. L., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M. M., Barasch, J., & Devarajan, P. (2007) · Critical Care · doi:10.1186/cc6192 · Cited by 483
Self-citationNGAL is an early predictive biomarker of contrast-induced nephropathy in children
Hirsch, R., Dent, C., Pfriem, H., Allen, J., Beekman, R. H., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M., & Devarajan, P. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0601-4 · Cited by 454
Self-citationBiomarkers in chronic kidney disease: a review
Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 449
Zhou, H., Pisitkun, T., Aponte, A., Yuen, P. S. T., Hoffert, J. D., Yasuda, H., Hu, X., Chawla, L., Shen, R.-F., Knepper, M. A., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001874 · Cited by 445
The Ngal reporter mouse detects the response of the kidney to injury in real time
Paragas, N., Qiu, A., Zhang, Q., Samstein, B., Deng, S.-X., Schmidt-Ott, K. M., Viltard, M., Yu, W., Forster, C. S., Gong, G., et al. (2011) · Nature Medicine · doi:10.1038/nm.2290 · Cited by 420
Self-citationBiomarkers in acute kidney injury – pathophysiological basis and clinical performance
Schrezenmeier, E. V., Barasch, J., Budde, K., Westhoff, T., & Schmidt‐Ott, K. M. (2017) · Acta Physiologica · doi:10.1111/apha.12764 · Cited by 401
Self-citationBiomarkers in chronic kidney disease, from kidney function to kidney damage
Lopez-Giacoman, S. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i1.57 · Cited by 392
Neutrophil gelatinase‐associated lipocalin (NGAL): A new marker of kidney disease
Devarajan, P. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802150158 · Cited by 378
Self-citationBiomarkers for the early detection of acute kidney injury
Nguyen, M. T., & Devarajan, P. (2008) · Pediatric Nephrology · doi:10.1007/s00467-007-0470-x · Cited by 373
Self-citationDEVARAJAN, P. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01317.x · Cited by 356
Self-citationKidney NGAL is a novel early marker of acute injury following transplantation
Mishra, J., Ma, Q., Kelly, C., Mitsnefes, M., Mori, K., Barasch, J., & Devarajan, P. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0055-0 · Cited by 354
Self-citationWheeler, D. S., Devarajan, P., Ma, Q., Harmon, K., Monaco, M., Cvijanovich, N., & Wong, H. R. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318169245a · Cited by 343
Self-citationNeutrophil Gelatinase-Associated Lipocalin: A� Promising Biomarker for Human Acute Kidney Injury
Devarajan, P. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.12 · Cited by 332
Self-citationKrawczeski, C. D., Goldstein, S. L., Woo, J. G., Wang, Y., Piyaphanee, N., Ma, Q., Bennett, M., & Devarajan, P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.017 · Cited by 332
Self-citationBagshaw, S. M., Bennett, M., Haase, M., Haase-Fielitz, A., Egi, M., Morimatsu, H., D’amico, G., Goldsmith, D., Devarajan, P., & Bellomo, R. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1724-9 · Cited by 328
Self-citationBiomarkers of nephrotoxic acute kidney injury
Ferguson, M. A., Vaidya, V. S., & Bonventre, J. V. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.024 · Cited by 322
The Origin of Multiple Molecular Forms in Urine of HNL/NGAL
Cai, L., Rubin, J., Han, W., Venge, P., & Xu, S. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00980110 · Cited by 295
Biomarkers of AKI: A Review of Mechanistic Relevance and Potential Therapeutic Implications
Alge, J. L., & Arthur, J. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12191213 · Cited by 294
Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption
Kashani, K., Cheungpasitporn, W., & Ronco, C. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0973 · Cited by 289
A basic science view of acute kidney injury biomarkers
Charlton, J. R., Portilla, D., & Okusa, M. D. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft510 · Cited by 286
Biomarkers of Drug-Induced Kidney Toxicity
Griffin, B. R., Faubel, S., & Edelstein, C. L. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000589 · Cited by 285
Biomarkers for the early detection of acute kidney injury
Devarajan, P. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328343f4dd · Cited by 284
Self-citationNeutrophil gelatinase‐associated lipocalin: pathophysiology and clinical applications
Singer, E., Markó, L., Paragas, N., Barasch, J., Dragun, D., Müller, D. N., Budde, K., & Schmidt‐Ott, K. M. (2013) · Acta Physiologica · doi:10.1111/apha.12054 · Cited by 282
Self-citationNew biomarkers of acute kidney injury
Parikh, C. R., & Devarajan, P. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318168c652 · Cited by 281
Self-citationHaase-Fielitz, A., Haase, M., & Devarajan, P. (2014) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563214521795 · Cited by 272
Self-citationBiomarkers of Acute Kidney Injury
Edelstein, C. L. (2008) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2008.04.003 · Cited by 272
Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury
Liu, S., Hartleben, B., Kretz, O., Wiech, T., Igarashi, P., Mizushima, N., Walz, G., & Huber, T. B. (2012) · Autophagy · doi:10.4161/auto.19419 · Cited by 271
de Geus, H. R. H., Bakker, J., Lesaffre, E. M. E. H., & le Noble, J. L. M. L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200908-1214oc · Cited by 269
Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven’t Worked and What Is on the Horizon
Jo, S. K., Rosner, M. H., & Okusa, M. D. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03280906 · Cited by 252
Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia
Schmidt-Ott, K. M., Mori, K., Kalandadze, A., Li, J.-Y., Paragas, N., Nicholas, T., Devarajan, P., & Barasch, J. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000232886.81142.58 · Cited by 237
Self-citationBioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity
DesRochers, T. M., Suter, L., Roth, A., & Kaplan, D. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059219 · Cited by 128
Adeosun, S. O., Gordon, D. M., Weeks, M. F., Moore, K. H., Hall, J. E., Hinds, T. D., & Stec, D. E. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00495.2017 · Cited by 73
“NGAL1 (LCN2) is a known marker of kidney damage and has been shown to be important for the progression of kidney disease (5, 35, 36).”
BackgroundWu, Y., Yang, L., Su, T., Wang, C., Liu, G., & Li, X.-M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02370310 · Cited by 69
Muller, P. Y., & Dieterle, F. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903114174 · Cited by 62
Metadata
- Authors
- Mishra, J., Mori, K., Ma, Q., Kelly, C., Barasch, J., & Devarajan, P.
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 24
- Issue
- 3
- Pages
- 307-315
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W2011250217
- Cited by
- 535
- References
- 30
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.